Detailed Forecast of the Next Generation Sequencing (NGS) Informatics Market
Next Generation Sequencing (NGS) Informatics Market : Key Trends and Projections
The Next Generation Sequencing (NGS) Informatics Market is set to reach $4.3 billion by 2030, growing at a CAGR of 15.4%, according to Meticulous Research®. Growth is driven by increased R&D investments, rising genetic disorder rates, and advancements in sequencing technologies.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=3483
Market Growth Drivers
- R&D Investments : Pharmaceutical and biotechnology companies are heavily investing in NGS technologies.
- Disease Prevalence : Higher rates of genetic disorders increase demand for advanced diagnostics.
- Technological Progress : Innovations in NGS informatics enhance data analysis and management.
- Government Initiatives : Supportive policies for genomic research contribute to market growth.
Market Segmentation
- Offering : Software solutions are expected to dominate due to their efficiency in managing large datasets.
- Application : Drug discovery is the largest segment, driven by decreased sequencing costs and high R&D investment.
- End User : Pharmaceutical and biotech companies are the largest users of NGS informatics.
- Geography : North America leads, with strong growth anticipated in Asia-Pacific.
Challenges and Opportunities
Challenges include data security issues and a shortage of skilled professionals. Opportunities lie in expanding NGS tool adoption and advancements in bioinformatics.
Top Market Players
Leading companies include Illumina, Thermo Fisher Scientific, Roche, Qiagen, and Agilent Technologies.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
